mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |